Bridge City Capital, LLC Pacira Bio Sciences, Inc. Transaction History
Bridge City Capital, LLC
- $325 Million
- Q1 2025
A detailed history of Bridge City Capital, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Bridge City Capital, LLC holds 172,146 shares of PCRX stock, worth $4.04 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
172,146
Previous 229,196
24.89%
Holding current value
$4.04 Million
Previous $4.32 Million
0.69%
% of portfolio
1.32%
Previous 1.16%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$188 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$123 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$53.2 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$52.6 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$48.1 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.08B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...